semaglutide vision loss VA Clinicians Should Counsel Initiators About a 2-Fold Greater Risk of From 'Eye Stroke' GLP-1 drugs and vision loss:

Importantly, the researchers did not identify any relationship between these serious adverse events and the use of retatrutide

Another possibility is that portal hypertension in cirrhosis may show the characteristics of spleen enlargement in the early stage, and the occurrence of spleen enlargement may be accompanied by hypersplenism, which will further affect the immune function of the body, thus aggravating the development of liver cirrhosis ( Liver cirrhosis and hepatopulmonary syndrome Hepatopulsyndrome (HPS), first proposed by Knudson and Kennedy in 1977 (Weinfurtner and Forde, 2020)

Novo Nordisk, the company that makes the drugs, reportedthat in 2022, 81% of Wegovypatients were women

Ricks says in a statement

Cagrilintide is a promising investigational peptide that has demonstrated favorable safety and tolerability profiles across multiple Phase 2 and Phase 3 clinical trials, including cardiac safety monitoring